Glaukos Total Long-Term Assets 2014-2025 | GKOS

Glaukos total long-term assets from 2014 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Glaukos total long-term assets for the quarter ending March 31, 2025 were $0.522B, a 4.24% decline year-over-year.
  • Glaukos total long-term assets for 2024 were $0.525B, a 3.67% decline from 2023.
  • Glaukos total long-term assets for 2023 were $0.545B, a 2.43% decline from 2022.
  • Glaukos total long-term assets for 2022 were $0.559B, a 0.9% decline from 2021.
Glaukos Annual Total Long-Term Assets
(Millions of US $)
2024 $525
2023 $545
2022 $559
2021 $564
2020 $536
2019 $556
2018 $30
2017 $16
2016 $14
2015 $13
2014 $15
2013 $19
Glaukos Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $522
2024-12-31 $525
2024-09-30 $529
2024-06-30 $536
2024-03-31 $545
2023-12-31 $545
2023-09-30 $549
2023-06-30 $555
2023-03-31 $557
2022-12-31 $559
2022-09-30 $560
2022-06-30 $560
2022-03-31 $561
2021-12-31 $564
2021-09-30 $562
2021-06-30 $553
2021-03-31 $548
2020-12-31 $536
2020-09-30 $540
2020-06-30 $543
2020-03-31 $548
2019-12-31 $556
2019-09-30 $98
2019-06-30 $101
2019-03-31 $44
2018-12-31 $30
2018-09-30 $15
2018-06-30 $16
2018-03-31 $16
2017-12-31 $16
2017-09-30 $15
2017-06-30 $14
2017-03-31 $14
2016-12-31 $14
2016-09-30 $15
2016-06-30 $12
2016-03-31 $12
2015-12-31 $13
2015-09-30 $13
2015-06-30 $14
2015-03-31 $15
2014-12-31 $15
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $22
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.388B $0.383B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $180.563B 21.85
Intuitive Surgical (ISRG) United States $177.754B 73.68
Edwards Lifesciences (EW) United States $46.928B 31.13
IDEXX Laboratories (IDXX) United States $45.454B 52.24
Alcon (ALC) Switzerland $45.309B 30.62
DexCom (DXCM) United States $34.894B 53.93
IQVIA Holdings (IQV) United States $33.859B 19.13
Mettler-Toledo (MTD) United States $26.269B 31.24
STERIS (STE) Ireland $22.671B 24.97
Waters (WAT) United States $18.028B 25.44
SONOVA HOLDING (SONVY) Switzerland $17.531B 0.00
Hologic (HOLX) United States $14.819B 16.10
Sysmex ADR (SSMXY) Japan $10.682B 30.30
Penumbra (PEN) United States $9.027B 70.85
Masimo (MASI) United States $8.926B 32.92
Globus Medical (GMED) United States $7.375B 17.57
Teleflex (TFX) United States $5.179B 8.55
Integer Holdings (ITGR) United States $3.786B 18.97
TransMedics (TMDX) United States $3.657B 79.50
PROCEPT BioRobotics (PRCT) United States $3.083B 0.00
LivaNova (LIVN) United Kingdom $2.381B 14.18
Nihon Kohden (NHNKY) Japan $2.144B 24.59
Elekta AB (EKTAY) Sweden $1.991B 17.90
Veracyte (VCYT) United States $1.977B 27.75
Alphatec Holdings (ATEC) United States $1.582B 0.00
Artivion (AORT) United States $1.341B 125.60
OPKO Health (OPK) United States $1.086B 0.00
Tandem Diabetes Care (TNDM) United States $1.058B 0.00
Integra LifeSciences Holdings (IART) United States $1.019B 5.42
Pulse Biosciences (PLSE) United States $1.004B 0.00
SiBone (SIBN) United States $0.735B 0.00
IRadimed (IRMD) United States $0.716B 36.33
Beta Bionics (BBNX) United States $0.643B 0.00
AxoGen (AXGN) United States $0.609B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.555B 8.64
OrthoPediatrics (KIDS) United States $0.553B 0.00
Semler Scientific (SMLR) United States $0.525B 11.30
Pacific Biosciences Of California (PACB) United States $0.462B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.442B 0.00
Mesa Laboratories (MLAB) United States $0.416B 9.67
Delcath Systems (DCTH) United States $0.397B 0.00
AngioDynamics (ANGO) United States $0.375B 0.00
Treace Medical Concepts (TMCI) United States $0.358B 0.00
RxSight (RXST) United States $0.324B 0.00
ClearPoint Neuro (CLPT) United States $0.314B 0.00
Neuronetics (STIM) United States $0.297B 0.00
NeuroPace (NPCE) United States $0.295B 0.00
908 Devices (MASS) United States $0.266B 0.00
Alpha Tau Medical (DRTS) Israel $0.260B 0.00
Tactile Systems Technology (TCMD) United States $0.245B 14.86
CVRx (CVRX) United States $0.217B 0.00
Monogram Orthopaedics (MGRM) United States $0.203B 0.00
Inogen (INGN) United States $0.183B 0.00
Sight Sciences (SGHT) United States $0.180B 0.00
Rapid Micro Biosystems (RPID) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Accuray (ARAY) United States $0.140B 0.00
Biosig Technologies (BSGM) United States $0.131B 0.00
Lucid Diagnostics (LUCD) United States $0.120B 0.00
Anteris Technologies Global (AVR) Australia $0.117B 0.00
Atossa Genetics (ATOS) United States $0.108B 0.00
Microbot Medical (MBOT) United States $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.091B 55.10
EnVVeno Medical (NVNO) United States $0.087B 0.00
Hyperfine (HYPR) United States $0.084B 0.00
InspireMD (NSPR) United States $0.074B 0.00
Vicarious Surgical (RBOT) United States $0.067B 0.00
Spectral AI (MDAI) United States $0.066B 0.00
QT Imaging Holdings (QTIH) United States $0.053B 0.00
Covalon Technologies (CVALF) Canada $0.053B 21.44
EDAP TMS S.A (EDAP) France $0.052B 0.00
Positron (POSC) United States $0.051B 0.00
WORK Medical Technology Group (WOK) China $0.047B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.018B 0.00
Baird Medical Investment Holdings (BDMD) $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.10